This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

10 Mid-Cap Stocks That Have Almost Doubled in 2012 (Update2)

Stocks in this article: FOSL LSI PMTC REGN SWKS TPX PAY WTW ATHN TDC

5. AthenaHealth (ATHN)

Company profile: AthenaHealth, with a market value of $2.6 billion, provides Internet-based business services to physician practices.

Investor takeaway: Its shares are up 47% this year and have a three-year average annual return of 39%. Analysts give them three "buy" ratings, two "buy/holds," 13 "holds," one "weak hold," and two "sells," according to a survey of analysts by S&P.

4. Skyworks Solutions (SWKS)

Company profile: Skyworks Solutions, with a market value of $5 billion, makess semiconductor components for wireless handsets, including power amplifiers, integrated front-end modules, and direct conversion radios.

Investor takeaway: Its shares are up 51% this year and have a three-year average annual return of 55%. Analysts give them 11 "buy" ratings, five "buy/holds," and three "holds," according to a survey of analysts by S&P. It's expected to earn $1.87 per share this year and grow by 11% next year.

3. Tempur-Pedic International (TPX)

Company profile: Tempur-Pedic International, with a market value of $5 billion, makes viscoelastic foam mattresses, pillows, and other sleep system products, which, packaged together, can run several thousand dollars.

Investor takeaway: Its shares are up 52% this year and have a three-year average annual return of 161%. Analysts give them nine "buy" ratings, two "buy/holds," and four "holds," according to a survey of analysts by S&P. It's expected to earn $3.99 per share this year, and grow by 17% to $4.67 in 2013.

2. Fossil (FOSL)

Company profile: Fossil, with a market value of $8 billion, makes wristwatches under the Fossil, Relic and Zodiac brand names, along with a complementary line of leather goods, sunglasses and jewelry. Its products are sold in department and specialty retail stores.

Investor takeaway: Its shares are up 55% this year and have a three-year average annual return of 119%. Analysts give them five "buy" ratings, five "buy/holds," and five "holds," per S&P. S&P, which has it "buy"-rated with a $125 price target, an 11% premium.

1. Regeneron (REGN)

Company profile: Regeneron, with a market value of $10 billion, discovers, develops, and commercializes products that fight inflammation, cancer, and eye disease. Last year, it won FDA approval and launched EYLEA for the treatment of wet age-related macular degeneration.

Investor takeaway: Its shares are up 89% this year and have a three-year average annual return of 102%. Analysts give them eight "buy" ratings, one "buy/hold," and seven "holds," according to a survey of analysts by S&P. S&P has it rated "hold," due to its recent share-price jump, but said it has a "robust" pipeline of potential new products.

>>To see these stocks in action, visit the 10 Mid-Cap Stocks That Have Almost Doubled in 2012 portfolio on Stockpickr.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
3 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs